The contribution of positron emission tomography to the study of ischemic heart failure

David P. Dutka, Paolo G. Camici

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.

Original languageEnglish
Pages (from-to)399-418
Number of pages20
JournalProgress in Cardiovascular Diseases
Volume43
Issue number5
DOIs
Publication statusPublished - 2001

Fingerprint

Ventricular Dysfunction
Positron-Emission Tomography
Heart Failure
Cardiovascular Physiological Phenomena
Regional Blood Flow
Coronary Artery Disease
Sensitivity and Specificity
Health

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The contribution of positron emission tomography to the study of ischemic heart failure. / Dutka, David P.; Camici, Paolo G.

In: Progress in Cardiovascular Diseases, Vol. 43, No. 5, 2001, p. 399-418.

Research output: Contribution to journalArticle

@article{1f6e098ca63e4c8e894fa94af17070d6,
title = "The contribution of positron emission tomography to the study of ischemic heart failure",
abstract = "Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.",
author = "Dutka, {David P.} and Camici, {Paolo G.}",
year = "2001",
doi = "10.1053/pcad.2001.20673",
language = "English",
volume = "43",
pages = "399--418",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - The contribution of positron emission tomography to the study of ischemic heart failure

AU - Dutka, David P.

AU - Camici, Paolo G.

PY - 2001

Y1 - 2001

N2 - Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.

AB - Cardiac imaging with positron emission tomography offers unrivaled sensitivity and specificity to probe cardiovascular physiology in health and disease. The use of positron emission tomography to noninvasively measure regional myocardial blood flow and assess myocardial viability in patients with ventricular dysfunction and coronary artery disease has contributed greatly to our understanding of the pathophysiology of ischemic heart failure. The advances and the need for further studies to establish both the natural history of such ventricular dysfunction and the role of coronary revascularization are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035103389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035103389&partnerID=8YFLogxK

U2 - 10.1053/pcad.2001.20673

DO - 10.1053/pcad.2001.20673

M3 - Article

VL - 43

SP - 399

EP - 418

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 5

ER -